Details of the Drug

General Information of Drug (ID: DM5XRMA)

Drug Name

Tipapkinogene sovacivec

Indication

Disease Entry	ICD 11	Status	REF
Cervical Intraepithelial neoplasia	2E66.1	Phase 2	[1]
------------------------------------------------------------------------------------

Cross-matching ID

Molecular Interaction Atlas of This Drug

Drug Therapeutic Target (DTT)

DTT Name	DTT ID	UniProt ID	MOA	REF
Human papillomavirus protein E6 (HPV E6)	TTE2N95	VE6_HPV16	Modulator	[2]
Human papillomavirus protein E7 (HPV E7)	TT3CPZW	VE7_HPV16	Modulator	[2]

------------------------------------------------------------------------------------

Molecular Interaction Atlas (MIA)

Jump to Detail Molecular Interaction Atlas of This Drug

References

1	ClinicalTrials.gov (NCT01022346) A Study of RO5217790 (HPV Targeted Immunotherapy) in Patients With High Grade Cervical Intraepithelial Neoplasia Associated With High Risk HPV Infection. U.S. National Institutes of Health.
2	Immune therapy for human papillomaviruses-related cancers